FDA
approval
· 2008-05-09
FDA Approved: TACLONEX — Original Application (LEO Pharma Inc.)
Summary
FDA approved Taclonex, a topical combination of calcipotriol and betamethasone dipropionate, under Original Application by LEO Pharma Inc. for treatment of plaq…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TACLONEX (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE)